Search - tctmd.com

Displaying 421 - 440 of 744

Sort: Relevancy | Date

News Daily News

Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave

Shelley Wood

January 22, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Todd Neale

January 13, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for January

Todd Neale

January 01, 2021

News CV Team Pro

NorthShore University Health System

L.A. McKeown

December 30, 2020

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

Shelley Wood

December 28, 2020

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Shelley Wood

December 23, 2020

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

L.A. McKeown

December 18, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Features

Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine

Shelley Wood

December 10, 2020

News Opinion CV Team Dispatch

December 2020 News Roundup

L.A. McKeown

December 01, 2020

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for December

Todd Neale

December 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Conference News VIVA 2020

As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice

L.A. McKeown

November 27, 2020

News Daily News

CAC Testing Improves Pretest Probability of Obstructive CAD

Michael O'Riordan

November 23, 2020

News Daily News

Anthony Gershlick, Esteemed UK Cardiologist, Dies at 69

L.A. McKeown

November 20, 2020

Advertisement

Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave

FDA Approves Vericiguat for High-risk Patients With HF

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

COVID-19: TCTMD’s Daily Dispatch for January

NorthShore University Health System

The Biggest News of 2020: TCTMD’s Top 10

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine

December 2020 News Roundup

More Women Than Men Develop HF or Die After STEMI

COVID-19: TCTMD’s Daily Dispatch for December

TCTMD’s Top 10 Most Popular Stories for November 2020

As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice

CAC Testing Improves Pretest Probability of Obstructive CAD

Anthony Gershlick, Esteemed UK Cardiologist, Dies at 69

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content